Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$165 Mln
Revenue (TTM)
$-- Mln
Net Profit (TTM)
$-- Mln
ROE
-0.5 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
2.5
Industry P/E
27.54
EV/EBITDA
0.8
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$-1
Face value
--
Shares outstanding
39,332,200
CFO
$-210.74 Mln
EBITDA
$-206.52 Mln
Net Profit
$-245.05 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Rapid Micro Biosystems Inc (RPID)
| 292.8 | 14.8 | 47.9 | 353.2 | -1.9 | -- | -- |
|
BSE Sensex
| 3.7 | -1.6 | 9.6 | 5.9 | 14.3 | 19.1 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
|---|---|---|---|
|
Rapid Micro Biosystems Inc (RPID)
| 21.4 | -34.5 | -89.4 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Rapid Micro Biosystems Inc (RPID)
|
3.5 | 164.8 | -- | -- | -- | -- | -- | 2.5 |
| 20.9 | 5,221.1 | 459.4 | 206.8 | 25.6 | 68.3 | 26 | 13.3 | |
| 31.4 | 3,857.8 | 8.9 | -369.2 | -4,861.1 | -26.1 | -- | 2.9 | |
| 105.5 | 5,321.5 | 432.2 | -278.3 | -64.1 | -380.9 | -- | 100.0 | |
| 56.8 | 10,961.9 | 2,937.8 | 523.9 | 23.2 | 9.3 | 21.2 | 1.9 | |
| 39.7 | 7,414.9 | 127.4 | -668.0 | -432.9 | -- | -- | 123.7 | |
| 70.9 | 7,554.7 | 685.5 | 132.9 | 15.6 | 20.1 | 60.4 | 11.0 | |
| 14.0 | 7,087.1 | 4,427.0 | 373.0 | -0.7 | 5.8 | 18.5 | 1.1 | |
| 84.6 | 4,206.2 | 1,137.8 | 214.6 | 29.2 | 12.3 | 19.6 | 2.3 | |
| 9.1 | 10,539.7 | 14,317.0 | -3,790.1 | -23.7 | -21.4 | -- | 0.7 |
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany,... Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. Address: 25 Hartwell Avenue, Lexington, MA, United States, 02421 Read more
CEO, President & Director
Mr. Robert G. Spignesi Jr.
CEO, President & Director
Mr. Robert G. Spignesi Jr.
Headquarters
Lexington, MA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Rapid Micro Biosystems Inc (RPID) stood at $ 100 Mln as on 31-Mar-25
The share price of Rapid Micro Biosystems Inc (RPID) is $3.54 (NASDAQ) as of 13-Jun-2025 12:22 EDT. Rapid Micro Biosystems Inc (RPID) has given a return of -1.95% in the last 3 years.
Rapid Micro Biosystems Inc (RPID) has a market capitalisation of $ 165 Mln as on 12-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Rapid Micro Biosystems Inc (RPID) is 2.52 times as on 12-Jun-2025, a 47% discount to its peers’ median range of 4.78 times.
Since, TTM earnings of Rapid Micro Biosystems Inc (RPID) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Rapid Micro Biosystems Inc (RPID) and enter the required number of quantities and click on buy to purchase the shares of Rapid Micro Biosystems Inc (RPID).
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. Address: 25 Hartwell Avenue, Lexington, MA, United States, 02421
The CEO & director of Mr. Robert G. Spignesi Jr.. is Rapid Micro Biosystems Inc (RPID), and CFO & Sr. VP is Mr. Robert G. Spignesi Jr..
There is no promoter pledging in Rapid Micro Biosystems Inc (RPID).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,096
|
|
|
1,054
|
|
|
755
|
|
|
741
|
|
|
709
|
|
|
532
|
|
|
522
|
|
|
421
|
|
|
386
|
| Rapid Micro Biosystems Inc (RPID) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Rapid Micro Biosystems Inc (RPID) was No Profit.
$-0.08
(
